Onconetix Inc (ONCO)
1.13
+0.05
(+4.63%)
USD |
NASDAQ |
Nov 21, 16:00
1.32
+0.19
(+16.81%)
After-Hours: 07:39
Onconetix Debt to Equity Ratio: -0.4216 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.4216 |
| March 31, 2024 | -0.7102 |
| Date | Value |
|---|---|
| December 31, 2023 | -1.738 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.738
Minimum
Dec 2023
-0.4216
Maximum
Jun 2024
-0.9567
Average
-0.7102
Median
Mar 2024
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.9382 |
| IGC Pharma Inc | 0.0183 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Protalix BioTherapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 59.46M |
| Total Liabilities (Quarterly) | 88.19M |
| Shareholders Equity (Quarterly) | -35.81M |
| Current Ratio | 0.0988 |